Acute Eosinophilic Pneumonia Secondary to Daptomycin: A Report of Three Cases

doi:doi:10.1086/652656

dc.contributor.author	Miller, Rebecca	en_US
dc.contributor.author	Gray, Alice	en_US
dc.contributor.author	LeBlanc, Thomas W.	en_US
dc.contributor.author	Sexton, Daniel	en_US
dc.date.accessioned	2011-06-21T17:27:21Z
dc.date.available	2011-06-21T17:27:21Z
dc.date.issued	2010	en_US
dc.identifier.citation	Miller,Becky A.;Gray,Alice;LeBlanc,Thomas W.;Sexton,Daniel J.;Martin,Andrew R.;Slama,Thomas G.. 2010. Acute Eosinophilic Pneumonia Secondary to Daptomycin: A Report of Three Cases. Clinical Infectious Diseases 50(11): E63-E68.	en_US
dc.identifier.issn	1058-4838	en_US
dc.identifier.uri	http://hdl.handle.net/10161/4150
dc.description.abstract	We describe 3 cases of daptomycin-induced pulmonary toxic effects that are consistent with drug-induced acute eosinophilic pneumonia. Patients presented similarly with dyspnea, cough, hypoxia, and diffuse ground-glass opacities at chest computed tomography. Clinical suspicion for this adverse drug event and cessation of daptomycin until definitive diagnosis can be made is crucial.	en_US
dc.language.iso	en_US	en_US
dc.publisher	UNIV CHICAGO PRESS	en_US
dc.relation.isversionof	doi:10.1086/652656	en_US
dc.subject	immunology	en_US
dc.subject	infectious diseases	en_US
dc.subject	microbiology	en_US
dc.title	Acute Eosinophilic Pneumonia Secondary to Daptomycin: A Report of Three Cases	en_US
dc.title.alternative		en_US
dc.description.version	Version of Record	en_US
duke.date.pubdate	2010-6-1	en_US
duke.description.endpage	E68	en_US
duke.description.issue	11	en_US
duke.description.startpage	E63	en_US
duke.description.volume	50	en_US
dc.relation.journal	Clinical Infectious Diseases	en_US